WeVote
Log In

Bill

Bill

S 10051

Requires epinephrine auto-injector devices at children's overnight, summer day and traveling summer camps

2025 Regular Session Introduced by Sam Sutton

Requires on-site epinephrine devices at youth camps with a formal collaborative agreement with an emergency health care provider, plus trained staff and reporting.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 10051

Summary of Bill S. 10051 (2025-2026, New York)

Purpose and Intent

  • Requires epinephrine auto-injector devices to be available at certain youth camps in New York.
  • The bill aims to ensure timely access to epinephrine in emergency situations at children's overnight camps, summer day camps, and traveling summer day camps by formalizing a required program and provider arrangements.

Key Provisions

1) Definitions and Eligibility (Section 1 and subsection amendments)

  • Revises the list of “eligible persons or entities” in the public health law to include a broader set of covered entities operating or employing staff at camps (and related entities) as part of the public health framework. The new structure clarifies who may be covered or regulated under related provisions.

2) New Section: Epinephrine Devices Required (Section 2, § 1392-b)

  • Establishes a new statutory section requiring epinephrine devices at the specified camps.
  • Definitions: “Emergency health care provider” includes:
    • A physician with emergency care experience, or
    • A hospital licensed under NY’s public health law that provides emergency care.
  • Collaborative Agreement (2a–2b):
    • Every operator of a children's overnight camp, summer day camp, or traveling summer day camp must maintain a collaborative agreement with an emergency health care provider.
    • An epinephrine device must be on the premises.
    • The collaborative agreement must include written practice protocols, and policies and procedures, ensuring compliance.
    • A copy of the collaborative agreement must be filed with the New York Department of Health and with the relevant regional council before using any epinephrine device.
  • Possession and Use (Section 3):
    • Only individuals who have completed a department-approved training course on the use of epinephrine devices may possess/use them.
    • The use, maintenance, and disposal of epinephrine devices must follow department regulations.
    • Every use of an epinephrine device must be immediately reported to the emergency health care provider.

3) Application of Other Laws (Section 2, § 1392-b(4))

  • Use of an epinephrine device under this section is considered first aid or emergency treatment for liability purposes.
  • Acquisition or possession of an epinephrine device under this act does not constitute unlawful practice of a profession.
  • Other authorized sellers/providers may sell or provide epinephrine devices to those authorized under this section.

Who Is Affected

  • Operators of:
    • Children's overnight camps
    • Summer day camps
    • Traveling summer day camps
  • Emergency health care providers (physicians, hospitals) who will enter collaborative agreements.
  • Camp staff and personnel who handle epinephrine devices (subject to training).
  • Department of Health and regional councils, which will receive copies of collaborative agreements.

Timelines and Procedures

  • Implementation: The act takes effect 180 days after it becomes law.
  • Pre-implementation steps: Camp operators must establish a collaborative agreement with an emergency health care provider, implement written protocols, and file the agreement with the department and regional council prior to using epinephrine devices.
  • Compliance: Training for possession/use is required; medical responses must be reported to the emergency health care provider immediately.

Practical Impact

  • Improves readiness for anaphylaxis management at youth camps by mandating:
    • On-site epinephrine devices
    • Formal collaboration with emergency health care providers
    • Documented protocols, training, and reporting procedures
  • Creates a clearer regulatory framework governing storage, use, disposal, and liability related to epinephrine devices in camp settings.
  • Establishes oversight through the Department of Health and regional councils.

Administrative Details

  • Introduced in Senate by Sen. Sutton (with co-sponsor).
  • Referred to Health Committee on April 24, 2026.
  • Effective date: 180 days after enactment; regulatory changes may begin on or before the effective date.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.